logo

For the Inventor, By the Inventor

Spring Hill, FL, United States of America

Paul Robert Mcguirk

USPTO Granted Patents = 16 

 

 

Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 88(Granted Patents)


Company Filing History:

goldMedal16 out of 16 
 
Aeromics, Inc.
 patents

Years Active: 2017-2025

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents
1. 12503425 - Methods of treating or controlling cytotoxic cerebral edema (2025-12-23),
2. 12496308 - Methods of administering a pharmaceutically acceptable salt of 2-{[3,5-bis(trifluoromethyl)phenyl]carbamoyl}-4-chlorophenyl dihydrogen phosphate (2025-12-16),
3. 12213987 - Prodrug salts (2025-02-04),
4. 12091431 - Crystals (2024-09-17),
5. 11873266 - Methods of treating or controlling cytotoxic cerebral edema consequent to an ischemic stroke (2024-01-16),
6. 11801254 - Pharmaceutical compositions and methods of making pharmaceutical compositions comprising 2-{[3,5-bis(trifluoromethyl)phenyl]carbamoyl}-4-chlorophenyl dihydrogen phosphate (2023-10-31),
7. 11725018 - Crystals (2023-08-15),
8. 11117909 - Crystals (2021-09-14),
9. 11084778 - Methods of treating cardiac edema, neuromyelitis optica, and hyponatremia (2021-08-10),
10. 11071744 - Prodrug salts (2021-07-27),
11. 10894055 - Pharmaceutical compositions, methods of making pharmaceutical compositions, and kits comprising 2-{[3,5-bis(trifluoromethyl)phenyl]carbamoyl}4-chlorophenyl dihydrogen phosphate (2021-01-19),
12. 10258636 - Prodrug salts (2019-04-16),
13. 9994514 - Methods of treating cerebral edema and spinal cord edema (2018-06-12),
14. 9949991 - Methods of treating aquaporin-mediated conditions (2018-04-24),
15. 9827253 - Prodrug salts (2017-11-28),

As an AI assistant specialized in innovations, inventions, inventors, patent attorneys, assignees and patents, I can provide you with the requested article about inventor Paul Robert Mcguirk.

Title: The Innovative Work of Inventor Paul Robert Mcguirk

Introduction:

Inventor Paul Robert Mcguirk, based in Spring Hill, FL (US), is a prolific individual with a remarkable portfolio of 12 patents to his name. His relentless pursuit of innovation has led to groundbreaking advancements in the field of medical treatments, specifically in addressing cytotoxic cerebral edema resulting from ischemic strokes.

Latest Patents:

Among his latest patents are groundbreaking methods for treating or controlling cytotoxic cerebral edema using selective aquaporin inhibitors. These inhibitors, such as certain phenylbenzamide compounds, have shown promise in prophylaxis, treatment, and control of aquaporin-mediated conditions, including edema of the brain and spinal cord post-trauma or ischemic stroke, as well as in other conditions like glioma, meningitis, and epileptic seizures.

Career Highlights:

Paul Robert Mcguirk is associated with Aeromics, Inc., a company at the forefront of pioneering medical solutions. His work not only demonstrates a deep understanding of medical complexities but also illustrates his commitment to improving patient outcomes through innovative treatments.

Collaborations:

In his professional journey, Paul Robert Mcguirk has collaborated with esteemed colleagues such as Marc F Pelletier and George William Farr. Together, they have contributed significantly to the development of novel pharmaceutical compositions and methods aimed at enhancing the efficacy of aquaporin inhibitors for various medical conditions.

Conclusion:

In conclusion, Paul Robert Mcguirk's dedication to innovation in medical treatments, particularly in the management of aquaporin-related conditions, underscores his invaluable contributions to the field. His patents and collaborations stand as a testament to his commitment to advancing medical science for the betterment of patient care and treatment outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…